Lateral flow assay device
US-2016041163-A1 · Feb 11, 2016 · US
US12558688B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12558688-B2 |
| Application number | US-202017072332-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 16, 2020 |
| Priority date | Mar 18, 2016 |
| Publication date | Feb 24, 2026 |
| Grant date | Feb 24, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A combination of components in a capillary flow channel uses capillary forces to passively control the movement of liquid samples within a microfluidic device. To detect a target, a liquid sample introduced to a proximal portion of capillary channel of a microfluidic device moves by capillary action along the specific components of capillary channel.
Opening claim text (preview).
What is claimed is: 1 . A microfluidic device comprising: a port configured to receive a liquid sample, a filter pocket, a mixing well, and a capillary flow channel; wherein the capillary flow channel comprises a proximal opening, a distal opening, a dry reagent zone, a pinch region, and a detection zone; wherein the filter pocket comprises a filter and disposed substantially at the proximal opening; wherein the mixing well comprises a length, a width, a height, and a perimeter, the width decreasing from a central portion of the mixing well toward the perimeter along at least two opposed directions, wherein the mixing well is disposed distal to the filter pocket; wherein the dry reagent zone containing a reagent, the dry reagent zone disposed distal to the mixing well; wherein the pinch region is configured to redirect flow, wherein the pinch region is disposed distal to the dry reagent zone and has a width that is less than that of the capillary flow channel; wherein the pinch region has a width that is at most half the width of the capillary flow channel; wherein the detection zone is disposed distal to a fluid resistance feature, wherein the distal opening is tapered to control a flow rate, and wherein the filter pocket, the mixing well, the dry reagent zone, pinch region, and the detection zone are in fluidic communication. 2 . The microfluidic device of claim 1 , wherein the filter pocket comprises a sample inlet having a recess configured to receive a liquid sample, a filter landing, and a vent configured to permit air to be displaced upon receiving the liquid sample. 3 . The microfluidic device of claim 2 , wherein the filter landing includes a raised plateau extending from a distal edge of the filter pocket. 4 . The microfluidic device of claim 2 , wherein the filter pocket further comprises a catwalk strip disposed for directing a fluid deposited at the sample inlet to the filter landing. 5 . The microfluidic device of claim 1 , wherein the mixing well is dimensioned to move a filtered liquid sample by capillary action. 6 . The microfluidic device of claim 1 , wherein the dry reagent zone contains walls with a hydrophobic ink. 7 . The microfluidic device of claim 1 , wherein the pinch region is configured with a lobe, optionally wherein the pinch region comprises a portion of the capillary flow channel that is lobed in a direction that is substantially perpendicular to a length of the microfluidic device. 8 . The microfluidic device of claim 1 , wherein the detection zone contains at least one solid phase capture spot configured to bind a specific analyte. 9 . The microfluidic device of claim 1 , further comprising two or more solid phase capture spots arranged in a series along a length of the detection zone. 10 . The microfluidic device of claim 8 , wherein the at least one solid phase capture spot provides a signal measured by a reader. 11 . The microfluidic device of claim 1 , further comprising a waste channel distal to the detection zone. 12 . The microfluidic device of claim 11 , wherein a portion of a substrate covers the waste channel and that portion is printed with hydrophobic ink that increases flow rate and decreases wash time. 13 . The microfluidic device of claim 1 , wherein the capillary flow channel is disposed between an upper substrate and a lower substrate. 14 . The microfluidic device of claim 13 , wherein the lower substrate comprises a first portion having a first depth and a second portion having a second depth that is less than the first depth. 15 . The microfluidic device of claim 14 , wherein a portion having a first depth is convex and a portion having a second depth is planar. 16 . The microfluidic device of claim 1 , wherein the filter pocket is configured to move liquid by capillary action along the capillary flow channel and into the mixing well of the capillary flow channel. 17 . The microfluidic device of claim 7 , wherein the mixing well is configured to move liquid by capillary action along the capillary flow channel and into the pinch region of the capillary flow channel. 18 . The microfluidic device of claim 1 , wherein the mixing well comprises a depth that is greater than a depth of the capillary flow channel. 19 . A method for determining a presence or an absence of a cardiac troponin in a patient sample, comprising: placing a blood sample on a microfluidic device of claim 1 to label the cardiac troponin, if present in the patient sample, with a label comprising a binding partner for the cardiac troponin and a detectable moiety; and detecting a presence of cardiac troponin in the patient sample by determining a presence or an absence of the label, wherein detection of the presence of the label indicates the presence of cardiac troponin in the patient sample, wherein an assay has a limit of quantitation of about 3 μg/mL with a coefficient of variation of less than about 20%. 20 . The method of claim 19 , wherein the cardiac troponin is cardiac troponin I (cTnI). 21 . The method of claim 19 , wherein the cardiac troponin is cardiac troponin T (cTnT). 22 . The method of claim 19 , wherein the cardiac troponin is a complex of cTnI and cTnT. 23 . The microfluidic device of claim 1 , wherein the mixing well is substantially bowl-shaped.
from muscle, cartilage or connective tissue · CPC title
Solid-phase reaction mechanisms · CPC title
Serpentine channels · CPC title
characterised by venting arrangements · CPC title
by separating the blood components (G01N15/05 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.